Farjah Algahtani: Stroke Incidence and Risk Factors in Saudi Patients with Sickle Cell Disease
Farjah Algahtani, Director of Epidemiology and Public Health Research at King Saud University, Professor Of Hematology, shared a post onĀ LinkedIn about a recent article he and his colleagues co-authored, published in British Journal of Haematology, adding:
“As we mark Sickle Cell Disease Awareness Month, I am especially proud to contribute to improving our understanding of this complex disease and its complications in our Saudi population.
There is still much to learn about the unique phenotypes, risk factors, and long-term outcomes of patients with SCD.
I am sharing the results of our longitudinal study, ‘Stroke Incidence and Phenotype in Saudi Patients with Sickle Cell Disease,’ published in the British Journal of Haematology.
In this study of 195 Saudi patients with SCD, followed for a median of 13.5 years, we explored the incidence, phenotype, and laboratory correlates of stroke. Our findings highlight an important age-related pattern of stroke and the significant burden of both overt stroke and silent cerebral infarction.
We also found that higher LDH was associated with increased ischaemic stroke risk, while HbF showed a potentially protective effect.
I would like to extend my sincere thanks and appreciation to all the authors and collaborators for their valuable contributions and dedication to this important work.
Most importantly, a special thank you to our patients and their families, whose participation and trust made this research possible.
I hope that through continued research, collaboration, and awareness, we can contribute more to improving the lives and outcomes of people living with sickle cell disease.
Proud to be part of this important work and to collaborate with my colleagues at King Saud University.”
Title: Stroke incidence and phenotype in Saudi patients with sickle cell disease: A longitudinal cohort study
Authors: Mohammed Al-Agha, Fahad Albadr, Aamer Aleem, Farjah H. Algahtani, Ali Al-Shehri, Fahad Bashiri, Abdulrahman Alsultan

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?